Skip to main content
. Author manuscript; available in PMC: 2017 May 10.
Published in final edited form as: Anticancer Res. 2017 Feb;37(2):445–453. doi: 10.21873/anticanres.11336

Figure 3. STAT3 binds STAT1 and the interactions were enhanced with IL6 and TNF-α co-treatments and abolished with salinomycin challenge.

Figure 3

(A) Co-immunoprecipitation revealed that STAT3 binds STAT1. When co-treated with IL6 and TNF-α, the interactions were enhanced. (B) Salinomycin challenge has abolished the STAT3-STAT1 interactions.